PDRX
Price
$2.41
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Capitalization
N/A
SHPMY
Price
$8.00
Change
-$0.06 (-0.74%)
Updated
Jul 30 closing price
Capitalization
9.5B
Interact to see
Advertisement

PDRX vs SHPMY

Header iconPDRX vs SHPMY Comparison
Open Charts PDRX vs SHPMYBanner chart's image
PD-RX Pharmaceuticals
Price$2.41
Change-$0.00 (-0.00%)
Volume$315
CapitalizationN/A
Shanghai Pharmaceuticals Holdings
Price$8.00
Change-$0.06 (-0.74%)
Volume$761
Capitalization9.5B
PDRX vs SHPMY Comparison Chart in %
Loading...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDRX vs. SHPMY commentary
Aug 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDRX is a Hold and SHPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 01, 2025
Stock price -- (PDRX: $2.41 vs. SHPMY: $8.00)
Brand notoriety: PDRX and SHPMY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: PDRX: 7% vs. SHPMY: 168%
Market capitalization -- PDRX: $0 vs. SHPMY: $9.5B
PDRX [@Medical Distributors] is valued at $0. SHPMY’s [@Medical Distributors] market capitalization is $9.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDRX’s FA Score shows that 0 FA rating(s) are green whileSHPMY’s FA Score has 0 green FA rating(s).

  • PDRX’s FA Score: 0 green, 5 red.
  • SHPMY’s FA Score: 0 green, 5 red.
According to our system of comparison, SHPMY is a better buy in the long-term than PDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHPMY’s TA Score shows that 0 TA indicator(s) are bullish.

  • SHPMY’s TA Score: 0 bullish, 3 bearish.

Price Growth

PDRX (@Medical Distributors) experienced а 0.00% price change this week, while SHPMY (@Medical Distributors) price change was +9.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -1.16%. For the same industry, the average monthly price growth was +4.65%, and the average quarterly price growth was +0.45%.

Reported Earning Dates

SHPMY is expected to report earnings on Apr 28, 2025.

Industries' Descriptions

@Medical Distributors (-1.16% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMY YTD gains are higher at: -1.350 vs. PDRX (-20.984).
PDRXSHPMYPDRX / SHPMY
CapitalizationN/A9.5B-
EBITDAN/A11.1B-
Gain YTD-20.984-1.3501,554%
P/E RatioN/A8.39-
RevenueN/A241B-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PDRX vs SHPMY: Fundamental Ratings
PDRX
SHPMY
OUTLOOK RATING
1..100
4791
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
60
Fair valued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
10080
PRICE GROWTH RATING
1..100
7943
P/E GROWTH RATING
1..100
10063
SEASONALITY SCORE
1..100
40n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDRX's Valuation (40) in the null industry is in the same range as SHPMY (60). This means that PDRX’s stock grew similarly to SHPMY’s over the last 12 months.

SHPMY's Profit vs Risk Rating (85) in the null industry is in the same range as PDRX (100). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

SHPMY's SMR Rating (80) in the null industry is in the same range as PDRX (100). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

SHPMY's Price Growth Rating (43) in the null industry is somewhat better than the same rating for PDRX (79). This means that SHPMY’s stock grew somewhat faster than PDRX’s over the last 12 months.

SHPMY's P/E Growth Rating (63) in the null industry is somewhat better than the same rating for PDRX (100). This means that SHPMY’s stock grew somewhat faster than PDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDRXSHPMY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
38%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
66%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
31%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
27%
Bullish Trend 1 day ago
58%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FVC35.81N/A
+0.01%
First Trust Dorsey Wright Dynamic Foc 5
EVUS30.18-0.08
-0.28%
iShares ESG Aware MSCI USA Value ETF
XCNY25.76-0.08
-0.29%
SPDR S&P Emerging Markets ex-China ETF
FAS166.37-3.50
-2.06%
Direxion Daily Financial Bull 3X ETF
MSOS2.83-0.12
-4.07%
AdvisorShares Pure US Cannabis ETF

PDRX and

Correlation & Price change

A.I.dvisor tells us that PDRX and NSVGF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDRX and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDRX
1D Price
Change %
PDRX100%
N/A
NSVGF - PDRX
8%
Poorly correlated
N/A
MAHLY - PDRX
2%
Poorly correlated
N/A
SHPMY - PDRX
0%
Poorly correlated
N/A
ARRJF - PDRX
0%
Poorly correlated
N/A
MEPDF - PDRX
0%
Poorly correlated
N/A
More

SHPMY and

Correlation & Price change

A.I.dvisor tells us that SHPMY and NSVGF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMY
1D Price
Change %
SHPMY100%
N/A
NSVGF - SHPMY
14%
Poorly correlated
N/A
COSM - SHPMY
12%
Poorly correlated
+2.77%
SHTDF - SHPMY
12%
Poorly correlated
N/A
ZYXI - SHPMY
7%
Poorly correlated
-10.31%
SHPMF - SHPMY
7%
Poorly correlated
N/A
More